{
 "drug": "Scopolamine Transdermal System",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "11/03/2025",
 "dayN": 295,
 "cat": "Gastroenterology",
 "companies": [
  "Padagis US LLC"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "11/03/2025",
   "update_type": "New",
   "initial_posting_date": "11/03/2025",
   "package_ndc": "45802-580-46",
   "generic_name": "Scopolamine Transdermal System",
   "contact_info": "866-634-9120",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA078830"
    ],
    "brand_name": [
     "SCOPOLAMINE TRANSDERMAL SYSTEM"
    ],
    "generic_name": [
     "SCOPOLAMINE TRANSDERMAL SYSTEM"
    ],
    "manufacturer_name": [
     "Padagis Israel Pharmaceuticals Ltd"
    ],
    "product_ndc": [
     "45802-580"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "TRANSDERMAL"
    ],
    "substance_name": [
     "SCOPOLAMINE"
    ],
    "rxcui": [
     "226552"
    ],
    "spl_id": [
     "d334a21d-7546-477f-a66a-f95b2cf523ce"
    ],
    "spl_set_id": [
     "cb93bfad-3e37-4a27-92f6-f21703ae7bdf"
    ],
    "package_ndc": [
     "45802-580-84",
     "45802-580-46",
     "45802-580-62",
     "45802-580-01"
    ],
    "nui": [
     "N0000175574",
     "N0000175370"
    ],
    "pharm_class_epc": [
     "Anticholinergic [EPC]"
    ],
    "pharm_class_moa": [
     "Cholinergic Antagonists [MoA]"
    ],
    "unii": [
     "DL48G20X8X"
    ]
   },
   "update_date": "11/03/2025",
   "therapeutic_category": [
    "Gastroenterology",
    "Neurology",
    "Other"
   ],
   "dosage_form": "Transdermal System",
   "presentation": "Scopolamine, Transdermal System, 1 mg (NDC 45802-580-46)",
   "company_name": "Padagis US LLC",
   "status": "To Be Discontinued"
  }
 ]
}